Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628949 · ClinicalTrials.gov registry record · NA
A Single-Use Duodenoscope in a Real-World Setting
A NA study of Endoscopic Retrograde Cholangiopancreatography (ERCP), sponsored by Ambu A/S.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 9
- Study locations
NCT04628949: Completed NA study of Endoscopic Retrograde Cholangiopancreatography (ERCP), sponsored by Ambu A/S.
NCT04628949 is a NA study of Endoscopic Retrograde Cholangiopancreatography (ERCP) that has completed, run by Ambu A/S. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04628949, a NA study of Endoscopic Retrograde Cholangiopancreatography (ERCP), has completed, sponsored by Ambu A/S.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study will assess how the aScope™ Duodeno endoscope performs in procedures that treat problems of the bile and pancreatic ducts.
Primary Outcome
Procedure success will be defined as the successful completion of the ERCP procedure with the aScope™ Duodeno endoscope. The procedural success rate will be the incidence rate of success for the ERCP procedure.
Conditions Studied
Interventions
- DEVICE aScope™ Duodeno endoscope and aBox™ Duodeno
Study Locations (9)
New York
- NYU Langone Health - New York
- Mount Sinai South Nassau - Oceanside
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado Hospital - Aurora
Illinois
- Southwest Gastroenterology - Oak Lawn
Indiana
- Indiana University, University Hospital - Indianapolis
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic Foundation - Cleveland
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
What the finished NCT04628949 record still lists
NCT04628949 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Endoscopic Retrograde Cholangiopancreatography (ERCP) appearing as the primary indexed condition, and to 1 intervention - of which aScope™ Duodeno endoscope and aBox™ Duodeno is the first listed.
NCT04628949 lists 9 locations in 8 states (New York, Alabama, Colorado).
Frequently Asked Questions
What is clinical trial NCT04628949 about?
NCT04628949 is a clinical study titled "A Single-Use Duodenoscope in a Real-World Setting". This study will assess how the aScope™ Duodeno endoscope performs in procedures that treat problems of the bile and pancreatic ducts.
What is the current status of trial NCT04628949?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2021-01-25. Estimated completion is 2022-02-28.
What conditions does trial NCT04628949 study?
This clinical trial studies the following conditions: Endoscopic Retrograde Cholangiopancreatography (ERCP).
What interventions are being tested in trial NCT04628949?
The interventions under investigation include: aScope™ Duodeno endoscope and aBox™ Duodeno (DEVICE).
Who is sponsoring clinical trial NCT04628949?
This trial is sponsored by Ambu A/S, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04628949 being conducted?
This trial has 9 study locations across Alabama, Colorado, Illinois, Indiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04628949's enrollment target sits among peer trials
248 434th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI